Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Clinicopathologic assay of 15 tumor resections in a family with neurofibromatosis type 2.

Di Maio S, Mrak G, Juric-Sekhar G, Born D, Mantovani A, Sekhar LN.

J Neurol Surg B Skull Base. 2012 Apr;73(2):90-103. doi: 10.1055/s-0032-1301394.

2.

Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.

Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER.

J Neurosurg. 1996 May;84(5):847-51.

PMID:
8622160
3.

Management of multiple tumors in neurofibromatosis type 2 patients.

Aboukais R, Bonne NX, Baroncini M, Zairi F, Schapira S, Vincent C, Lejeune JP.

Neurochirurgie. 2015 Jun 9. pii: S0028-3770(15)00055-7. doi: 10.1016/j.neuchi.2014.11.012. [Epub ahead of print]

PMID:
26071178
4.

Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.

Sun S, Liu A.

J Neurosurg. 2014 Dec;121 Suppl:143-9. doi: 10.3171/2014.8.GKS141503.

PMID:
25434947
5.

Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article..

Holman MA, Schmitt WR, Carlson ML, Driscoll CL, Beatty CW, Link MJ.

J Neurosurg Pediatr. 2013 Oct;12(4):317-24. doi: 10.3171/2013.6.PEDS1383. Epub 2013 Aug 2.

PMID:
23909617
6.

Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.

Choi JW, Lee JY, Phi JH, Wang KC, Chung HT, Paek SH, Kim DG, Park SH, Kim SK.

J Neurosurg Pediatr. 2014 Jun;13(6):650-7. doi: 10.3171/2014.3.PEDS13455. Epub 2014 Apr 11.

PMID:
24724714
7.

Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.

Mahboubi H, Maducdoc MM, Yau AY, Ziai K, Ghavami Y, Badran KW, Al-Thobaiti M, Brandon B, Djalilian HR.

Otolaryngol Head Neck Surg. 2015 Nov;153(5):822-31. doi: 10.1177/0194599815573223. Epub 2015 Mar 19.

PMID:
25791708
8.

Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.

Dewan R, Pemov A, Kim HJ, Morgan KL, Vasquez RA, Chittiboina P, Wang X, Chandrasekharappa SC, Ray-Chaudhury A, Butman JA, Stewart DR, Asthagiri AR.

Neuro Oncol. 2015 Apr;17(4):566-73. doi: 10.1093/neuonc/nou317. Epub 2014 Dec 1.

10.

Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.

Aghi M, Kluwe L, Webster MT, Jacoby LB, Barker FG 2nd, Ojemann RG, Mautner VF, MacCollin M.

J Neurosurg. 2006 Feb;104(2):201-7.

PMID:
16509493
11.

Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

Kley N, Whaley J, Seizinger BR.

Glia. 1995 Nov;15(3):297-307. Review.

PMID:
8586465
12.

Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.

Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N, et al.

Am J Hum Genet. 1994 Jun;54(6):1022-9.

13.

Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients.

Nowak A, Dziedzic T, Czernicki T, Kunert P, Marchel A.

Neurol Neurochir Pol. 2015;49(6):367-72. doi: 10.1016/j.pjnns.2015.08.007. Epub 2015 Sep 11.

PMID:
26652870
14.

Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.

Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.

Am J Otol. 1997 Nov;18(6):754-60.

PMID:
9391673
15.

Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Evans DG, Watson C, King A, Wallace AJ, Baser ME.

J Med Genet. 2005 Jan;42(1):45-8.

16.

Management of the patient and family with neurofibromatosis 2: a consensus conference statement.

Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R.

Br J Neurosurg. 2005 Feb;19(1):5-12. Review.

PMID:
16147576
17.

Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Dirks MS, Butman JA, Kim HJ, Wu T, Morgan K, Tran AP, Lonser RR, Asthagiri AR.

J Neurosurg. 2012 Jul;117(1):109-17. doi: 10.3171/2012.3.JNS111649. Epub 2012 Apr 13.

18.

The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.

Baser ME; Contributors to the International NF2 Mutation Database.

Hum Mutat. 2006 Apr;27(4):297-306. Review.

PMID:
16521120
19.

Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.

Nowak A, Dziedzic T, Czernicki T, Kunert P, Morawski K, Niemczyk K, Marchel A.

Neurol Neurochir Pol. 2015;49(5):295-301. doi: 10.1016/j.pjnns.2015.06.008. Epub 2015 Jul 3.

PMID:
26377980
20.

Intracranial meningiomas and neurofibromatosis type 2.

Aboukais R, Zairi F, Baroncini M, Bonne NX, Schapira S, Vincent C, Lejeune JP.

Acta Neurochir (Wien). 2013 Jun;155(6):997-1001; discussion 1001. doi: 10.1007/s00701-013-1692-2. Epub 2013 Apr 5.

PMID:
23558725

Supplemental Content

Support Center